Alosetron

Generic name: Pronounced as (al oh' se tron)
Brand names
  • Lotronex®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 07/15/2018

Alosetron may cause serious gastrointestinal (GI; affecting the stomach or intestines) side effects including ischemic colitis (decreased blood flow to the bowels) and severe constipation that may need to be treated in a hospital and may rarely cause death. Tell your doctor if you are taking any of the following medications: antihistamines; certain antidepressants ('mood elevators') called tricyclic antidepressants; or certain medications to treat asthma, diarrhea, lung disease, mental illness, motion sickness, overactive bladder, pain, Parkinson's disease, stomach or intestinal cramps, ulcers and upset stomach. Tell your doctor if you are constipated now, if you often have constipation, or if you have had problems resulting from constipation. Also tell your doctor if you have a blockage in your bowels, ischemic colitis, blood clots, or any disease that causes inflammation of the bowels such as Crohn's disease (swelling of the lining of the digestive tract), ulcerative colitis (a condition which causes swelling and sores in the lining of the colon [large intestine] and rectum), diverticulitis (small pouches in the lining of the large intestine that can become inflamed) or liver disease. Your doctor will probably tell you not to take alosetron.

Stop taking alosetron and call your doctor right away if you experience any of the following symptoms: constipation, new or worse pain in the abdomen (stomach area), or blood in your bowel movements. Call your doctor again if your constipation does not get better after you stop taking alosetron. Once you have stopped taking alosetron because of these symptoms, do not start taking it again unless your doctor tells you that you should.

Only certain doctors who are registered with the company that makes alosetron and who are aware of the possible side effects can write prescriptions for this medication. Your doctor will give you the manufacturer's patient information sheet (Medication Guide) before you begin treatment with alosetron and your pharmacist will give you a copy each time you refill your prescription. Read the information carefully and ask your doctor or pharmacist if you have any questions. You also can obtain the Medication Guide from the Food and Drug Administration (FDA) website (http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm) or the manufacturer's website.

Talk to your doctor about the risks of taking alosetron.

Alosetron is used to treat diarrhea, pain, cramps, and the feeling of an urgent need to have bowel movements caused by irritable bowel syndrome (IBS; a condition that causes stomach pain, bloating, constipation, and diarrhea) in women who have diarrhea as their main symptom and have not been helped by other treatments. Alosetron is in a class of medications called 5-HT3 receptor antagonists. Alosetron works by slowing the movement of stool (bowel movements) through the intestines.

Alosetron comes as a tablet to take by mouth. It is usually taken twice a day with or without food. Take alosetron at around the same times every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take alosetron exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Your doctor will probably start you on a low dose of alosetron. Your doctor will want to talk to you after you have taken the low dose for 4 weeks. If your symptoms are not controlled but you are not experiencing serious side effects of alosetron, your doctor may increase your dose. If you take the increased dose for 4 weeks and your symptoms are still not controlled, alosetron is not likely to help you. Stop taking alosetron and call your doctor.

Alosetron may control IBS but will not cure it. If alosetron helps you and you stop taking it, your IBS symptoms may return within 1 or 2 weeks.

Alosetron should not be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking alosetron,

  • tell your doctor and pharmacist if you are allergic to alosetron, any other medications, or any of the ingredients in alosetron tablets. Ask your pharmacist for a list of the ingredients..

  • tell your doctor if you are taking fluvoxamine (Luvox) or the medications listed in the IMPORTANT WARNING section, Your doctor will probably tell you not to take alosetron if you are taking one or more of these medications.

  • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: certain antifungals such as fluconazole (Diflucan), itraconazole (Sporanox), ketoconazole (Nizoral), and voriconazole (Vfend); cimetidine (Tagamet); clarithromycin (Biaxin, in Prevpac); fluoroquinolone antibiotics including ciprofloxacin (Cipro), gatifloxacin (Tequin), levofloxacin (Levaquin), norfloxacin (Noroxin), ofloxacin (Floxin), others; hydralazine (apresoline); isoniazid (INH, Nydrazid); certain medications for human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS) such as atazanavir (Reyataz), darunavir (Prezista), fosamprenavir (Lexiva), indinavir (Crixivan), lopinavir (in Kaletra), nelfinavir (Viracept), ritonavir (Norvir, in Kaletra), saquinavir (Fortovase, Invirase), and tipranavir (Aptivus); procainamide (Procanbid, Pronestyl); and telithromycin (Ketek). Many other medications may also interact with alosetron, so be sure to tell your doctor about all the medications you are taking, even those that do not appear on this list. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

  • tell your doctor if you have or have ever had the conditions listed in the IMPORTANT WARNING section or any stomach or bowel problems, surgery to your stomach or bowels, or kidney disease.

  • tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking alosetron, call your doctor.

Unless your doctor tells you otherwise, continue your normal diet.

Do not take a missed dose when you remember it. Skip the missed dose and take the next dose at the regularly scheduled time. Do not take a double dose to make up for a missed one.

  • Alosetron may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • upset stomach

    • swelling in the stomach area

    • hemorrhoids

  • Some side effects can be serious. If you experience any of the symptoms listed in the IMPORTANT WARNING section, call your doctor immediately.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from light, excess heat and moisture (not in the bathroom).

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Keep all appointments with your doctor.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Moxifloxacin Moxifloxacin The metabolism of Alosetron can be decreased when combined with Moxifloxacin.
Montelukast Montelukast The metabolism of Alosetron can be decreased when combined with Montelukast.
Insulin Glargine (rDNA origin) Injection Insulin Glargine (rDNA origin) Injection The metabolism of Alosetron can be increased when combined with Insulin glargine.
Leflunomide Leflunomide The serum concentration of Alosetron can be decreased when it is combined with Leflunomide.
Delavirdine Delavirdine The metabolism of Alosetron can be decreased when combined with Delavirdine.
Nevirapine Nevirapine The metabolism of Alosetron can be decreased when combined with Nevirapine.
Dolasetron Dolasetron The risk or severity of adverse effects can be increased when Dolasetron is combined with Alosetron.
Aminophylline Aminophylline The metabolism of Aminophylline can be decreased when combined with Alosetron.
Anagrelide Anagrelide The metabolism of Anagrelide can be decreased when combined with Alosetron.
Candesartan Candesartan The metabolism of Alosetron can be decreased when combined with Candesartan.
Cilostazol Cilostazol The metabolism of Cilostazol can be decreased when combined with Alosetron.
Clopidogrel Clopidogrel The metabolism of Clopidogrel can be decreased when combined with Alosetron.
Diphenoxylate Diphenoxylate The risk or severity of adverse effects can be increased when Alosetron is combined with Diphenoxylate.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) The metabolism of Conjugated estrogens can be decreased when combined with Alosetron.
Fenofibrate Fenofibrate The metabolism of Alosetron can be decreased when combined with Fenofibrate.
Guanfacine Guanfacine The risk or severity of adverse effects can be increased when Alosetron is combined with Guanfacine.
Naratriptan Naratriptan The risk or severity of adverse effects can be increased when Naratriptan is combined with Alosetron.
Paregoric Paregoric The risk or severity of adverse effects can be increased when Morphine is combined with Alosetron.
Pentazocine Pentazocine The risk or severity of adverse effects can be increased when Pentazocine is combined with Alosetron.
Ranitidine Ranitidine The metabolism of Ranitidine can be decreased when combined with Alosetron.
Reserpine Reserpine The risk or severity of adverse effects can be increased when Reserpine is combined with Alosetron.
Rizatriptan Rizatriptan The risk or severity of adverse effects can be increased when Rizatriptan is combined with Alosetron.
Sumatriptan Sumatriptan The risk or severity of adverse effects can be increased when Sumatriptan is combined with Alosetron.
Tizanidine Tizanidine The serum concentration of Tizanidine can be increased when it is combined with Alosetron.
Zolmitriptan Zolmitriptan The metabolism of Zolmitriptan can be decreased when combined with Alosetron.
Famotidine Injection Famotidine Injection The metabolism of Alosetron can be decreased when combined with Famotidine.
Fluconazole Injection Fluconazole Injection The metabolism of Alosetron can be decreased when combined with Fluconazole.
Hydromorphone Injection Hydromorphone Injection The risk or severity of adverse effects can be increased when Hydromorphone is combined with Alosetron.
Interferon Beta-1b Injection Interferon Beta-1b Injection The metabolism of Alosetron can be decreased when combined with Interferon beta-1b.
Interferon Gamma-1b Injection Interferon Gamma-1b Injection The metabolism of Alosetron can be decreased when combined with Interferon gamma-1b.
Levofloxacin Injection Levofloxacin Injection The metabolism of Alosetron can be decreased when combined with Levofloxacin.
Meperidine Injection Meperidine Injection The metabolism of Alosetron can be increased when combined with Meperidine.
Metoclopramide Injection Metoclopramide Injection The risk or severity of sedation can be increased when Alosetron is combined with Metoclopramide.
Metronidazole Injection Metronidazole Injection The metabolism of Alosetron can be decreased when combined with Metronidazole.
Morphine Injection Morphine Injection The risk or severity of adverse effects can be increased when Morphine is combined with Alosetron.
Zidovudine Injection Zidovudine Injection The metabolism of Alosetron can be decreased when combined with Zidovudine.
Altretamine Altretamine The risk or severity of adverse effects can be increased when Amphetamine is combined with Alosetron.
Ondansetron Ondansetron The metabolism of Alosetron can be decreased when combined with Ondansetron.
Granisetron Granisetron The risk or severity of adverse effects can be increased when Granisetron is combined with Alosetron.
Torsemide Torsemide The metabolism of Alosetron can be decreased when combined with Torasemide.
Olanzapine Olanzapine The metabolism of Olanzapine can be decreased when combined with Alosetron.
Entacapone Entacapone The risk or severity of adverse effects can be increased when Entacapone is combined with Alosetron.
Meloxicam Meloxicam The metabolism of Alosetron can be decreased when combined with Meloxicam.
Oxcarbazepine Oxcarbazepine The risk or severity of adverse effects can be increased when Oxcarbazepine is combined with Alosetron.
Zaleplon Zaleplon The risk or severity of adverse effects can be increased when Zaleplon is combined with Alosetron.
Anakinra Anakinra The metabolism of Alosetron can be increased when combined with Anakinra.
Desloratadine Desloratadine The risk or severity of adverse effects can be increased when Desloratadine is combined with Alosetron.
Linezolid Linezolid The risk or severity of adverse effects can be increased when Linezolid is combined with Alosetron.
Trimipramine Trimipramine The metabolism of Alosetron can be decreased when combined with Trimipramine.
Etanercept Injection Etanercept Injection The metabolism of Alosetron can be increased when combined with Etanercept.
Glycopyrrolate Glycopyrrolate Alosetron may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.
Modafinil Modafinil The metabolism of Alosetron can be increased when combined with Modafinil.
Epinephrine Injection Epinephrine Injection The metabolism of Alosetron can be decreased when combined with Epinephrine.
Escitalopram Escitalopram The risk or severity of adverse effects can be increased when Alosetron is combined with Escitalopram.
Zonisamide Zonisamide The risk or severity of adverse effects can be increased when Zonisamide is combined with Alosetron.
Adalimumab Injection Adalimumab Injection The metabolism of Alosetron can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole The risk or severity of adverse effects can be increased when Alosetron is combined with Aripiprazole.
Atomoxetine Atomoxetine The risk or severity of adverse effects can be increased when Atomoxetine is combined with Alosetron.
Dexmethylphenidate Dexmethylphenidate The risk or severity of adverse effects can be increased when Alosetron is combined with Dexmethylphenidate.
Atazanavir Atazanavir The metabolism of Atazanavir can be decreased when combined with Alosetron.
Almotriptan Almotriptan The risk or severity of adverse effects can be increased when Almotriptan is combined with Alosetron.
Eletriptan Eletriptan The risk or severity of adverse effects can be increased when Eletriptan is combined with Alosetron.
Rosuvastatin Rosuvastatin The metabolism of Rosuvastatin can be decreased when combined with Alosetron.
Aprepitant Aprepitant The metabolism of Alosetron can be decreased when combined with Aprepitant.
Interferon Beta-1a Subcutaneous Injection Interferon Beta-1a Subcutaneous Injection The metabolism of Alosetron can be decreased when combined with Interferon beta-1a.
Tegaserod Tegaserod The metabolism of Alosetron can be decreased when combined with Tegaserod.
Frovatriptan Frovatriptan The metabolism of Frovatriptan can be decreased when combined with Alosetron.
Gemifloxacin Gemifloxacin The metabolism of Alosetron can be decreased when combined with Gemifloxacin.
Progesterone Progesterone The metabolism of Alosetron can be decreased when combined with Progesterone.
Apomorphine Injection Apomorphine Injection The risk or severity of hypotension can be increased when Apomorphine is combined with Alosetron.
Infliximab Injection Infliximab Injection The metabolism of Alosetron can be increased when combined with Infliximab.
Oxandrolone Oxandrolone The metabolism of Alosetron can be decreased when combined with Oxandrolone.
Protriptyline Protriptyline The risk or severity of adverse effects can be increased when Protriptyline is combined with Alosetron.
Duloxetine Duloxetine The risk or severity of adverse effects can be increased when Alosetron is combined with Duloxetine.
Trospium Trospium Alosetron may increase the central nervous system depressant (CNS depressant) activities of Trospium.
Bosentan Bosentan The metabolism of Alosetron can be increased when combined with Bosentan.
Cinacalcet Cinacalcet The metabolism of Cinacalcet can be decreased when combined with Alosetron.
Erlotinib Erlotinib The metabolism of Erlotinib can be decreased when combined with Alosetron.
Eszopiclone Eszopiclone The risk or severity of CNS depression can be increased when Alosetron is combined with Eszopiclone.
Solifenacin Solifenacin Alosetron may increase the central nervous system depressant (CNS depressant) activities of Solifenacin.
Voriconazole Voriconazole The metabolism of Alosetron can be decreased when combined with Voriconazole.
Dextroamphetamine Dextroamphetamine The risk or severity of adverse effects can be increased when Amphetamine is combined with Alosetron.
Entecavir Entecavir The metabolism of Entecavir can be decreased when combined with Alosetron.
Peginterferon Alfa-2a Injection Peginterferon Alfa-2a Injection The metabolism of Alosetron can be decreased when combined with Peginterferon alfa-2a.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The serum concentration of Alosetron can be increased when it is combined with Peginterferon alfa-2b.
Sodium Oxybate Sodium Oxybate Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Alosetron.
Isocarboxazid Isocarboxazid The risk or severity of adverse effects can be increased when Alosetron is combined with Isocarboxazid.
Ramelteon Ramelteon The metabolism of Ramelteon can be decreased when combined with Alosetron.
Darifenacin Darifenacin Alosetron may increase the central nervous system depressant (CNS depressant) activities of Darifenacin.
Fentanyl Fentanyl The risk or severity of adverse effects can be increased when Fentanyl is combined with Alosetron.
Pregabalin Pregabalin The therapeutic efficacy of Alosetron can be increased when used in combination with Pregabalin.
Deferasirox Deferasirox The serum concentration of Alosetron can be increased when it is combined with Deferasirox.
Phenylephrine Phenylephrine The metabolism of Alosetron can be increased when combined with Phenylephrine.
Felbamate Felbamate The metabolism of Alosetron can be decreased when combined with Felbamate.
Abatacept Injection Abatacept Injection The metabolism of Alosetron can be increased when combined with Abatacept.
Rasagiline Rasagiline The metabolism of Rasagiline can be decreased when combined with Alosetron.
Imatinib Imatinib The metabolism of Imatinib can be decreased when combined with Alosetron.
Gefitinib Gefitinib The metabolism of Alosetron can be decreased when combined with Gefitinib.
Paliperidone Paliperidone The risk or severity of adverse effects can be increased when Alosetron is combined with Paliperidone.
Bortezomib Bortezomib The metabolism of Alosetron can be decreased when combined with Bortezomib.
Insulin Glulisine (rDNA origin) Injection Insulin Glulisine (rDNA origin) Injection The metabolism of Alosetron can be increased when combined with Insulin glulisine.
Primaquine Primaquine The metabolism of Primaquine can be decreased when combined with Alosetron.
Pemetrexed Injection Pemetrexed Injection The metabolism of Pemetrexed can be decreased when combined with Alosetron.
Dimenhydrinate Dimenhydrinate The risk or severity of adverse effects can be increased when Alosetron is combined with Dimenhydrinate.
Nabilone Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Alosetron.
Sorafenib Sorafenib The metabolism of Alosetron can be decreased when combined with Sorafenib.
Sunitinib Sunitinib The risk or severity of QTc prolongation and torsade de pointes can be increased when Sunitinib is combined with Alosetron.
Dronabinol Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Alosetron.
Levocetirizine Levocetirizine The risk or severity of adverse effects can be increased when Alosetron is combined with Levocetirizine.
Dasatinib Dasatinib The metabolism of Dasatinib can be decreased when combined with Alosetron.
Mexiletine Mexiletine The metabolism of Alosetron can be decreased when combined with Mexiletine.
Armodafinil Armodafinil The metabolism of Alosetron can be decreased when combined with Armodafinil.
Nilotinib Nilotinib The metabolism of Alosetron can be decreased when combined with Nilotinib.
Bexarotene Bexarotene The metabolism of Alosetron can be decreased when combined with Bexarotene.
OnabotulinumtoxinA Injection OnabotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Alosetron.
RimabotulinumtoxinB Injection RimabotulinumtoxinB Injection The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Alosetron.
Etravirine Etravirine The metabolism of Alosetron can be decreased when combined with Etravirine.
Desvenlafaxine Desvenlafaxine The risk or severity of adverse effects can be increased when Alosetron is combined with Desvenlafaxine.
Tretinoin Tretinoin The metabolism of Alosetron can be decreased when combined with Tretinoin.
Bendamustine Injection Bendamustine Injection The metabolism of Bendamustine can be decreased when combined with Alosetron.
Flecainide Flecainide The metabolism of Alosetron can be decreased when combined with Flecainide.
Certolizumab Injection Certolizumab Injection The metabolism of Alosetron can be increased when combined with Certolizumab pegol.
Praziquantel Praziquantel The metabolism of Praziquantel can be decreased when combined with Alosetron.
Rufinamide Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Alosetron.
Midazolam Midazolam The risk or severity of adverse effects can be increased when Midazolam is combined with Alosetron.
Eltrombopag Eltrombopag The metabolism of Eltrombopag can be decreased when combined with Alosetron.
Milnacipran Milnacipran The risk or severity of adverse effects can be increased when Alosetron is combined with Milnacipran.
Fesoterodine Fesoterodine Alosetron may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine.
Betaxolol Betaxolol The metabolism of Betaxolol can be decreased when combined with Alosetron.
Iloperidone Iloperidone The risk or severity of adverse effects can be increased when Alosetron is combined with Iloperidone.
Prasugrel Prasugrel The metabolism of Prasugrel can be decreased when combined with Alosetron.
Lacosamide Lacosamide The risk or severity of adverse effects can be increased when Alosetron is combined with Lacosamide.
AbobotulinumtoxinA Injection AbobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Alosetron.
Palonosetron Injection Palonosetron Injection The risk or severity of adverse effects can be increased when Palonosetron is combined with Alosetron.
Tapentadol Tapentadol Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Alosetron.
Golimumab Injection Golimumab Injection The metabolism of Alosetron can be increased when combined with Golimumab.
Pazopanib Pazopanib The metabolism of Pazopanib can be decreased when combined with Alosetron.
Asenapine Asenapine The metabolism of Asenapine can be decreased when combined with Alosetron.
Vigabatrin Vigabatrin The risk or severity of adverse effects can be increased when Alosetron is combined with Vigabatrin.
Pitavastatin Pitavastatin The metabolism of Pitavastatin can be decreased when combined with Alosetron.
Albendazole Albendazole The metabolism of Albendazole can be decreased when combined with Alosetron.
Oxymorphone Oxymorphone The risk or severity of adverse effects can be increased when Alosetron is combined with Oxymorphone.
Tocilizumab Injection Tocilizumab Injection The metabolism of Alosetron can be increased when combined with Tocilizumab.
IncobotulinumtoxinA Injection IncobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Alosetron.
Lurasidone Lurasidone The risk or severity of adverse effects can be increased when Alosetron is combined with Lurasidone.
Acetaminophen Injection Acetaminophen Injection Alosetron may increase the hepatotoxic activities of Acetaminophen.
Vilazodone Vilazodone The risk or severity of adverse effects can be increased when Alosetron is combined with Vilazodone.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Alosetron can be decreased when combined with Cyclophosphamide.
Abiraterone Abiraterone The serum concentration of Alosetron can be increased when it is combined with Abiraterone.
Ticagrelor Ticagrelor The metabolism of Alosetron can be decreased when combined with Ticagrelor.
Clobazam Clobazam The risk or severity of adverse effects can be increased when Clobazam is combined with Alosetron.
Vemurafenib Vemurafenib The serum concentration of Alosetron can be increased when it is combined with Vemurafenib.
Vismodegib Vismodegib The metabolism of Alosetron can be decreased when combined with Vismodegib.
Axitinib Axitinib The metabolism of Axitinib can be decreased when combined with Alosetron.
Cabergoline Cabergoline The risk or severity of adverse effects can be increased when Cabergoline is combined with Alosetron.
Ezogabine Ezogabine The risk or severity of adverse effects can be increased when Tiagabine is combined with Alosetron.
Enzalutamide Enzalutamide The metabolism of Alosetron can be increased when combined with Enzalutamide.
Regorafenib Regorafenib The metabolism of Alosetron can be decreased when combined with Regorafenib.
Teriflunomide Teriflunomide The serum concentration of Alosetron can be decreased when it is combined with Teriflunomide.
Cabozantinib (thyroid cancer) Cabozantinib (thyroid cancer) The metabolism of Cabozantinib can be decreased when combined with Alosetron.
Pomalidomide Pomalidomide The metabolism of Pomalidomide can be decreased when combined with Alosetron.
Apixaban Apixaban The metabolism of Apixaban can be decreased when combined with Alosetron.
Dabrafenib Dabrafenib The metabolism of Alosetron can be increased when combined with Dabrafenib.
Ospemifene Ospemifene The metabolism of Ospemifene can be decreased when combined with Alosetron.
Levomilnacipran Levomilnacipran The risk or severity of adverse effects can be increased when Alosetron is combined with Levomilnacipran.
Vortioxetine Vortioxetine The risk or severity of adverse effects can be increased when Alosetron is combined with Vortioxetine.
Perampanel Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Alosetron.
Ketorolac Injection Ketorolac Injection The metabolism of Alosetron can be decreased when combined with Ketorolac.
Simeprevir Simeprevir The metabolism of Alosetron can be decreased when combined with Simeprevir.
Dapagliflozin Dapagliflozin The metabolism of Alosetron can be decreased when combined with Dapagliflozin.
Apremilast Apremilast The metabolism of Alosetron can be increased when combined with Apremilast.
Ceritinib Ceritinib The metabolism of Alosetron can be decreased when combined with Ceritinib.
Siltuximab Injection Siltuximab Injection The metabolism of Alosetron can be increased when combined with Siltuximab.
Eslicarbazepine Eslicarbazepine The risk or severity of adverse effects can be increased when Alosetron is combined with Eslicarbazepine.
Belinostat Injection Belinostat Injection The metabolism of Alosetron can be increased when combined with Belinostat.
Testosterone Injection Testosterone Injection The metabolism of Alosetron can be decreased when combined with Testosterone.
Oritavancin Injection Oritavancin Injection The metabolism of Alosetron can be decreased when combined with Oritavancin.
Hydrocodone Hydrocodone Alosetron may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Suvorexant Suvorexant Alosetron may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Peginterferon Beta-1a Injection Peginterferon Beta-1a Injection The metabolism of Alosetron can be decreased when combined with Peginterferon beta-1a.
Methamphetamine Methamphetamine The risk or severity of adverse effects can be increased when Alosetron is combined with Metamfetamine.
Tasimelteon Tasimelteon The metabolism of Tasimelteon can be decreased when combined with Alosetron.
Pirfenidone Pirfenidone The serum concentration of Pirfenidone can be increased when it is combined with Alosetron.
Secukinumab Injection Secukinumab Injection The metabolism of Alosetron can be increased when combined with Secukinumab.
Risperidone Injection Risperidone Injection The risk or severity of adverse effects can be increased when Risperidone is combined with Alosetron.
Insulin Human Inhalation Insulin Human Inhalation The metabolism of Alosetron can be increased when combined with Insulin human.
Lenvatinib Lenvatinib The metabolism of Alosetron can be decreased when combined with Lenvatinib.
Haloperidol Injection Haloperidol Injection The risk or severity of CNS depression can be increased when Alosetron is combined with Haloperidol.
Flibanserin Flibanserin The risk or severity of adverse effects can be increased when Alosetron is combined with Flibanserin.
Brexpiprazole Brexpiprazole The risk or severity of adverse effects can be increased when Alosetron is combined with Brexpiprazole.
Ziprasidone Injection Ziprasidone Injection The risk or severity of adverse effects can be increased when Alosetron is combined with Ziprasidone.
Cariprazine Cariprazine The risk or severity of adverse effects can be increased when Alosetron is combined with Cariprazine.
Eluxadoline Eluxadoline Alosetron may increase the constipating activities of Eluxadoline.
Insulin Degludec (rDNA Origin) Injection Insulin Degludec (rDNA Origin) Injection The metabolism of Alosetron can be increased when combined with Insulin degludec.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Alosetron.
Osimertinib Osimertinib The serum concentration of Alosetron can be decreased when it is combined with Osimertinib.
Lesinurad Lesinurad The metabolism of Lesinurad can be decreased when combined with Alosetron.
Brivaracetam Injection Brivaracetam Injection The risk or severity of adverse effects can be increased when Alosetron is combined with Brivaracetam.
Pimavanserin Pimavanserin The risk or severity of adverse effects can be increased when Alosetron is combined with Pimavanserin.
Obeticholic Acid Obeticholic Acid The metabolism of Alosetron can be decreased when combined with Obeticholic acid.
Diphenhydramine Injection Diphenhydramine Injection The risk or severity of adverse effects can be increased when Alosetron is combined with Diphenhydramine.
Rucaparib Rucaparib The metabolism of Rucaparib can be decreased when combined with Alosetron.
Doxepin (Insomnia) Doxepin (Insomnia) Alosetron may increase the central nervous system depressant (CNS depressant) activities of Doxepin.
Safinamide Safinamide The metabolism of Alosetron can be decreased when combined with Safinamide.
Midostaurin Midostaurin The metabolism of Alosetron can be decreased when combined with Midostaurin.
Enasidenib Enasidenib The metabolism of Enasidenib can be decreased when combined with Alosetron.
Delafloxacin Delafloxacin The metabolism of Alosetron can be increased when combined with Delafloxacin.
Buprenorphine Injection Buprenorphine Injection Alosetron may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Apalutamide Apalutamide The metabolism of Alosetron can be increased when combined with Apalutamide.
Avatrombopag Avatrombopag The metabolism of Alosetron can be increased when combined with Avatrombopag.
Lofexidine Lofexidine The therapeutic efficacy of Alosetron can be increased when used in combination with Lofexidine.
Binimetinib Binimetinib The metabolism of Binimetinib can be decreased when combined with Alosetron.
Cannabidiol Cannabidiol The risk or severity of adverse effects can be increased when Cannabidiol is combined with Alosetron.
Dacomitinib Dacomitinib The metabolism of Dacomitinib can be decreased when combined with Alosetron.
Stiripentol Stiripentol The metabolism of Alosetron can be decreased when combined with Stiripentol.
Gilteritinib Gilteritinib The therapeutic efficacy of Alosetron can be decreased when used in combination with Gilteritinib.
Rifamycin Rifamycin The metabolism of Alosetron can be decreased when combined with Rifamycin.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Alosetron can be increased when combined with Emapalumab.
Siponimod Siponimod The metabolism of Siponimod can be decreased when combined with Alosetron.
Acyclovir Ophthalmic Acyclovir Ophthalmic The metabolism of Acyclovir can be decreased when combined with Alosetron.
Erdafitinib Erdafitinib The metabolism of Erdafitinib can be decreased when combined with Alosetron.
Alpelisib Alpelisib The serum concentration of Alosetron can be decreased when it is combined with Alpelisib.
Brexanolone Injection Brexanolone Injection The risk or severity of adverse effects can be increased when Alosetron is combined with Brexanolone.
Solriamfetol Solriamfetol The risk or severity of adverse effects can be increased when Alosetron is combined with Solriamfetol.
Triclabendazole Triclabendazole The metabolism of Triclabendazole can be decreased when combined with Alosetron.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Alosetron.
Pitolisant Pitolisant The serum concentration of Alosetron can be decreased when it is combined with Pitolisant.
Phenytoin Injection Phenytoin Injection The metabolism of Alosetron can be decreased when combined with Phenytoin.
Fosphenytoin Injection Fosphenytoin Injection The metabolism of Alosetron can be decreased when combined with Fosphenytoin.
Voxelotor Voxelotor The metabolism of Voxelotor can be decreased when combined with Alosetron.
Avapritinib Avapritinib The metabolism of Avapritinib can be decreased when combined with Alosetron.
Lumateperone Lumateperone The risk or severity of adverse effects can be increased when Alosetron is combined with Lumateperone.
Lasmiditan Lasmiditan The risk or severity of adverse effects can be increased when Alosetron is combined with Lasmiditan.
Cenobamate Cenobamate The serum concentration of Alosetron can be decreased when it is combined with Cenobamate.
Selumetinib Selumetinib The metabolism of Selumetinib can be decreased when combined with Alosetron.
Tucatinib Tucatinib The metabolism of Tucatinib can be decreased when combined with Alosetron.
Capmatinib Capmatinib The metabolism of Alosetron can be decreased when combined with Capmatinib.
Lemborexant Lemborexant The risk or severity of adverse effects can be increased when Alosetron is combined with Lemborexant.
Fenfluramine Fenfluramine The risk or severity of adverse effects can be increased when Fenfluramine is combined with Alosetron.
Pralsetinib Pralsetinib The metabolism of Alosetron can be decreased when combined with Pralsetinib.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Alosetron can be decreased when it is combined with Satralizumab.
Viloxazine Viloxazine The risk or severity of adverse effects can be increased when Alosetron is combined with Viloxazine.
Theophylline Theophylline The metabolism of Theophylline can be decreased when combined with Alosetron.
Indomethacin Indomethacin The metabolism of Alosetron can be decreased when combined with Indomethacin.
Mefenamic Acid Mefenamic Acid The metabolism of Alosetron can be decreased when combined with Mefenamic acid.
Naproxen Naproxen The metabolism of Naproxen can be decreased when combined with Alosetron.
Trazodone Trazodone The risk or severity of adverse effects can be increased when Alosetron is combined with Trazodone.
Floxuridine Floxuridine The metabolism of Alosetron can be decreased when combined with Floxuridine.
Phenobarbital Phenobarbital The metabolism of Phenobarbital can be decreased when combined with Alosetron.
Metaxalone Metaxalone The risk or severity of adverse effects can be increased when Metaxalone is combined with Alosetron.
Levorphanol Levorphanol The risk or severity of adverse effects can be increased when Levorphanol is combined with Alosetron.
Primidone Primidone The metabolism of Alosetron can be increased when combined with Primidone.
Methsuximide Methsuximide The risk or severity of adverse effects can be increased when Alosetron is combined with Methsuximide.
Diethylpropion Diethylpropion The risk or severity of adverse effects can be increased when Diethylpropion is combined with Alosetron.
Chlorpromazine Chlorpromazine The metabolism of Chlorpromazine can be decreased when combined with Alosetron.
Diazepam Diazepam The risk or severity of adverse effects can be increased when Diazepam is combined with Alosetron.
Oxazepam Oxazepam The risk or severity of adverse effects can be increased when Oxazepam is combined with Alosetron.
Flurazepam Flurazepam The risk or severity of adverse effects can be increased when Flurazepam is combined with Alosetron.
Clorazepate Clorazepate The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Alosetron.
Lorazepam Lorazepam The risk or severity of adverse effects can be increased when Lorazepam is combined with Alosetron.
Carmustine Carmustine The metabolism of Carmustine can be decreased when combined with Alosetron.
Codeine Codeine The risk or severity of adverse effects can be increased when Codeine is combined with Alosetron.
Meprobamate Meprobamate The risk or severity of adverse effects can be increased when Meprobamate is combined with Alosetron.
Chlordiazepoxide Chlordiazepoxide The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Alosetron.
Bromocriptine Bromocriptine The risk or severity of adverse effects can be increased when Alosetron is combined with Bromocriptine.
Tranylcypromine Tranylcypromine The metabolism of Alosetron can be decreased when combined with Tranylcypromine.
Phenelzine Phenelzine The risk or severity of adverse effects can be increased when Phenelzine is combined with Alosetron.
Procarbazine Procarbazine The risk or severity of adverse effects can be increased when Alosetron is combined with Procarbazine.
Ergoloid Mesylates Ergoloid Mesylates The risk or severity of adverse effects can be increased when Alosetron is combined with Ergoloid mesylate.
Minocycline Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Alosetron.
Prochlorperazine Prochlorperazine The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Alosetron.
Thioridazine Thioridazine The risk or severity of adverse effects can be increased when Thioridazine is combined with Alosetron.
Trifluoperazine Trifluoperazine The metabolism of Trifluoperazine can be decreased when combined with Alosetron.
Dapsone Dapsone The metabolism of Alosetron can be decreased when combined with Dapsone.
Sulfadiazine Sulfadiazine The metabolism of Alosetron can be decreased when combined with Sulfadiazine.
Oxycodone Oxycodone The risk or severity of adverse effects can be increased when Oxycodone is combined with Alosetron.
Methadone Methadone The risk or severity of adverse effects can be increased when Methadone is combined with Alosetron.
Oxybutynin Oxybutynin Alosetron may increase the central nervous system depressant (CNS depressant) activities of Oxybutynin.
Benztropine Benztropine Alosetron may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
Maprotiline Maprotiline The metabolism of Maprotiline can be decreased when combined with Alosetron.
Ibuprofen Ibuprofen The metabolism of Ibuprofen can be decreased when combined with Alosetron.
Trihexyphenidyl Trihexyphenidyl Alosetron may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.
Orphenadrine Orphenadrine Alosetron may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Perphenazine Perphenazine The metabolism of Perphenazine can be decreased when combined with Alosetron.
Azathioprine Azathioprine The metabolism of Azathioprine can be decreased when combined with Alosetron.
Fluphenazine Fluphenazine The risk or severity of adverse effects can be increased when Fluphenazine is combined with Alosetron.
Amoxapine Amoxapine The risk or severity of adverse effects can be increased when Amoxapine is combined with Alosetron.
Carbamazepine Carbamazepine The metabolism of Alosetron can be increased when combined with Carbamazepine.
Molindone Molindone The risk or severity of adverse effects can be increased when Alosetron is combined with Molindone.
Clonidine Clonidine The risk or severity of sedation can be increased when Clonidine is combined with Alosetron.
Cimetidine Cimetidine The metabolism of Alosetron can be decreased when combined with Cimetidine.
Warfarin Warfarin The metabolism of Alosetron can be decreased when combined with Warfarin.
Clonazepam Clonazepam The risk or severity of adverse effects can be increased when Alosetron is combined with Clonazepam.
Promethazine Promethazine The metabolism of Alosetron can be decreased when combined with Promethazine.
Griseofulvin Griseofulvin The metabolism of Alosetron can be increased when combined with Griseofulvin.
Loxapine Loxapine The risk or severity of adverse effects can be increased when Loxapine is combined with Alosetron.
Quinine Quinine The metabolism of Quinine can be decreased when combined with Alosetron.
Ethosuximide Ethosuximide The risk or severity of adverse effects can be increased when Ethosuximide is combined with Alosetron.
Triamterene Triamterene The metabolism of Triamterene can be decreased when combined with Alosetron.
Sulfinpyrazone Sulfinpyrazone The metabolism of Alosetron can be decreased when combined with Sulfinpyrazone.
Secobarbital Secobarbital The metabolism of Alosetron can be increased when combined with Secobarbital.
Desipramine Desipramine Alosetron may increase the central nervous system depressant (CNS depressant) activities of Desipramine.
Amitriptyline Amitriptyline Amitriptyline may increase the central nervous system depressant (CNS depressant) activities of Alosetron.
Imipramine Imipramine The metabolism of Imipramine can be decreased when combined with Alosetron.
Probenecid Probenecid The metabolism of Alosetron can be decreased when combined with Probenecid.
Quinidine Quinidine The metabolism of Quinidine can be decreased when combined with Alosetron.
Isoniazid Isoniazid The metabolism of Alosetron can be decreased when combined with Isoniazid.
Rifampin Rifampin The metabolism of Alosetron can be increased when combined with Rifampicin.
Disopyramide Disopyramide The metabolism of Disopyramide can be decreased when combined with Alosetron.
Valproic Acid Valproic Acid The risk or severity of adverse effects can be increased when Valproic acid is combined with Alosetron.
Tamoxifen Tamoxifen The metabolism of Alosetron can be decreased when combined with Tamoxifen.
Butabarbital Butabarbital The risk or severity of adverse effects can be increased when Butabarbital is combined with Alosetron.
Methimazole Methimazole The metabolism of Alosetron can be decreased when combined with Methimazole.
Chlorpropamide Chlorpropamide The metabolism of Alosetron can be decreased when combined with Chlorpropamide.
Tolbutamide Tolbutamide The metabolism of Tolbutamide can be decreased when combined with Alosetron.
Tolazamide Tolazamide The metabolism of Alosetron can be decreased when combined with Tolazamide.
Dextromethorphan Dextromethorphan The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Alosetron.
Cyclobenzaprine Cyclobenzaprine The risk or severity of CNS depression can be increased when Alosetron is combined with Cyclobenzaprine.
Baclofen Baclofen The risk or severity of adverse effects can be increased when Baclofen is combined with Alosetron.
Doxylamine Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Alosetron.
Cyproheptadine Cyproheptadine The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Alosetron.
Clemastine Clemastine The risk or severity of adverse effects can be increased when Clemastine is combined with Alosetron.
Chlorpheniramine Chlorpheniramine The risk or severity of adverse effects can be increased when Alosetron is combined with Chlorpheniramine.
Brompheniramine Brompheniramine The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Alosetron.
Meclizine Meclizine The risk or severity of adverse effects can be increased when Meclizine is combined with Alosetron.
Dantrolene Dantrolene The risk or severity of adverse effects can be increased when Alosetron is combined with Dantrolene.
Chlorzoxazone Chlorzoxazone The metabolism of Chlorzoxazone can be decreased when combined with Alosetron.
Carisoprodol Carisoprodol The risk or severity of adverse effects can be increased when Carisoprodol is combined with Alosetron.
Methocarbamol Methocarbamol The risk or severity of adverse effects can be increased when Methocarbamol is combined with Alosetron.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The metabolism of Propranolol can be decreased when combined with Alosetron.
Nortriptyline Nortriptyline Alosetron may increase the central nervous system depressant (CNS depressant) activities of Nortriptyline.
Butorphanol Injection Butorphanol Injection The risk or severity of adverse effects can be increased when Butorphanol is combined with Alosetron.
Nalbuphine Injection Nalbuphine Injection The risk or severity of adverse effects can be increased when Nalbuphine is combined with Alosetron.
Trimethobenzamide Trimethobenzamide The risk or severity of adverse effects can be increased when Trimethobenzamide is combined with Alosetron.
Flavoxate Flavoxate Alosetron may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.
Fluorouracil Injection Fluorouracil Injection The metabolism of Fluorouracil can be decreased when combined with Alosetron.
Dacarbazine Dacarbazine The metabolism of Dacarbazine can be decreased when combined with Alosetron.
Acetazolamide Acetazolamide The risk or severity of adverse effects can be increased when Acetazolamide is combined with Alosetron.
Ketoconazole Ketoconazole The metabolism of Alosetron can be decreased when combined with Ketoconazole.
Pyrantel Pyrantel The risk or severity of adverse effects can be increased when Alosetron is combined with Pyrantel.
Hydroxyzine Hydroxyzine Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Alosetron.
Thiothixene Thiothixene The metabolism of Thiothixene can be decreased when combined with Alosetron.
Aspirin Aspirin The metabolism of Alosetron can be decreased when combined with Acetylsalicylic acid.
Alprazolam Alprazolam The risk or severity of adverse effects can be increased when Alprazolam is combined with Alosetron.
Temazepam Temazepam The risk or severity of adverse effects can be increased when Temazepam is combined with Alosetron.
Triazolam Triazolam The risk or severity of adverse effects can be increased when Triazolam is combined with Alosetron.
Dicyclomine Dicyclomine Alosetron may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Hyoscyamine Hyoscyamine Alosetron may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine.
Propantheline Propantheline Alosetron may increase the central nervous system depressant (CNS depressant) activities of Propantheline.
Trimethoprim Trimethoprim The metabolism of Alosetron can be decreased when combined with Trimethoprim.
Diltiazem Diltiazem The metabolism of Alosetron can be decreased when combined with Diltiazem.
Nifedipine Nifedipine The metabolism of Nifedipine can be decreased when combined with Alosetron.
Verapamil Verapamil The metabolism of Verapamil can be decreased when combined with Alosetron.
Pindolol Pindolol The risk or severity of adverse effects can be increased when Pindolol is combined with Alosetron.
Cisplatin Injection Cisplatin Injection The metabolism of Alosetron can be decreased when combined with Cisplatin.
Piroxicam Piroxicam The metabolism of Alosetron can be decreased when combined with Piroxicam.
Streptozocin Streptozocin The metabolism of Alosetron can be increased when combined with Streptozocin.
Etoposide Etoposide The metabolism of Etoposide can be decreased when combined with Alosetron.
Glyburide Glyburide The metabolism of Alosetron can be decreased when combined with Glyburide.
Glipizide Glipizide The metabolism of Glipizide can be decreased when combined with Alosetron.
Nafcillin Injection Nafcillin Injection The metabolism of Alosetron can be increased when combined with Nafcillin.
Pentoxifylline Pentoxifylline The metabolism of Pentoxifylline can be decreased when combined with Alosetron.
Gemfibrozil Gemfibrozil The metabolism of Alosetron can be decreased when combined with Gemfibrozil.
Guanabenz Guanabenz The metabolism of Guanabenz can be decreased when combined with Alosetron.
Pimozide Pimozide The metabolism of Pimozide can be decreased when combined with Alosetron.
Flurbiprofen Flurbiprofen The metabolism of Alosetron can be decreased when combined with Flurbiprofen.
Amiodarone Amiodarone The metabolism of Alosetron can be decreased when combined with Amiodarone.
Lovastatin Lovastatin The metabolism of Alosetron can be decreased when combined with Lovastatin.
Ciprofloxacin Ciprofloxacin The metabolism of Alosetron can be decreased when combined with Ciprofloxacin.
Diclofenac Diclofenac The metabolism of Diclofenac can be decreased when combined with Alosetron.
Fluoxetine Fluoxetine Alosetron may increase the central nervous system depressant (CNS depressant) activities of Fluoxetine.
Interferon Alfa-2b Injection Interferon Alfa-2b Injection The metabolism of Alosetron can be decreased when combined with Interferon alfa-2b.
Clozapine Clozapine The metabolism of Clozapine can be decreased when combined with Alosetron.
Estazolam Estazolam The risk or severity of adverse effects can be increased when Alosetron is combined with Estazolam.
Idarubicin Idarubicin The metabolism of Idarubicin can be decreased when combined with Alosetron.
Ofloxacin Ofloxacin The metabolism of Alosetron can be decreased when combined with Ofloxacin.
Etodolac Etodolac The metabolism of Alosetron can be decreased when combined with Etodolac.
Felodipine Felodipine The metabolism of Alosetron can be decreased when combined with Felodipine.
Nabumetone Nabumetone The metabolism of Nabumetone can be decreased when combined with Alosetron.
Simvastatin Simvastatin The metabolism of Alosetron can be decreased when combined with Simvastatin.
Teniposide Injection Teniposide Injection The metabolism of Alosetron can be decreased when combined with Teniposide.
Atovaquone Atovaquone The metabolism of Alosetron can be decreased when combined with Atovaquone.
Zolpidem Zolpidem Alosetron may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Doxazosin Doxazosin The metabolism of Alosetron can be decreased when combined with Doxazosin.
Omeprazole Omeprazole The metabolism of Alosetron can be increased when combined with Omeprazole.
Cisapride Cisapride The metabolism of Alosetron can be decreased when combined with Cisapride.
Gabapentin Gabapentin The risk or severity of adverse effects can be increased when Alosetron is combined with Gabapentin.
Fluvastatin Fluvastatin The metabolism of Alosetron can be decreased when combined with Fluvastatin.
Venlafaxine Venlafaxine The risk or severity of adverse effects can be increased when Venlafaxine is combined with Alosetron.
Fluvoxamine Fluvoxamine The metabolism of Alosetron can be decreased when combined with Fluvoxamine.
Nefazodone Nefazodone The risk or severity of adverse effects can be increased when Nefazodone is combined with Alosetron.
Lamotrigine Lamotrigine The risk or severity of adverse effects can be increased when Lamotrigine is combined with Alosetron.
Losartan Losartan The metabolism of Alosetron can be decreased when combined with Losartan.
Tramadol Tramadol The risk or severity of CNS depression can be increased when Alosetron is combined with Tramadol.
Lansoprazole Lansoprazole The metabolism of Alosetron can be decreased when combined with Lansoprazole.
Ifosfamide Injection Ifosfamide Injection The metabolism of Ifosfamide can be decreased when combined with Alosetron.
Nicardipine Nicardipine The metabolism of Alosetron can be decreased when combined with Nicardipine.
Bupropion Bupropion The risk or severity of adverse effects can be increased when Alosetron is combined with Bupropion.
Ticlopidine Ticlopidine The metabolism of Alosetron can be decreased when combined with Ticlopidine.
Riluzole Riluzole The metabolism of Riluzole can be decreased when combined with Alosetron.
Glimepiride Glimepiride The metabolism of Alosetron can be decreased when combined with Glimepiride.
Ritonavir Ritonavir The serum concentration of Alosetron can be increased when it is combined with Ritonavir.
Clomipramine Clomipramine The metabolism of Clomipramine can be decreased when combined with Alosetron.
Zafirlukast Zafirlukast The metabolism of Alosetron can be decreased when combined with Zafirlukast.
Mirtazapine Mirtazapine Alosetron may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Topiramate Topiramate The risk or severity of adverse effects can be increased when Topiramate is combined with Alosetron.
Zileuton Zileuton The metabolism of Zileuton can be decreased when combined with Alosetron.
Valsartan Valsartan The metabolism of Alosetron can be decreased when combined with Valsartan.
Insulin Lispro Injection Insulin Lispro Injection The metabolism of Alosetron can be increased when combined with Insulin lispro.
Pramipexole Pramipexole Alosetron may increase the sedative activities of Pramipexole.
Donepezil Donepezil The risk or severity of adverse effects can be increased when Donepezil is combined with Alosetron.
Nelfinavir Nelfinavir The metabolism of Alosetron can be decreased when combined with Nelfinavir.
Carvedilol Carvedilol The metabolism of Carvedilol can be decreased when combined with Alosetron.
Nilutamide Nilutamide The metabolism of Alosetron can be decreased when combined with Nilutamide.
Flutamide Flutamide The metabolism of Flutamide can be decreased when combined with Alosetron.
Selegiline Selegiline The metabolism of Alosetron can be decreased when combined with Selegiline.
Bicalutamide Bicalutamide The metabolism of Alosetron can be decreased when combined with Bicalutamide.
Sertraline Sertraline The risk or severity of adverse effects can be increased when Alosetron is combined with Sertraline.
Propafenone Propafenone The metabolism of Propafenone can be decreased when combined with Alosetron.
Irbesartan Irbesartan The metabolism of Irbesartan can be decreased when combined with Alosetron.
Ropinirole Ropinirole The risk or severity of adverse effects can be increased when Alosetron is combined with Ropinirole.
Quetiapine Quetiapine Alosetron may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Cetirizine Cetirizine The risk or severity of adverse effects can be increased when Cetirizine is combined with Alosetron.
Paroxetine Paroxetine The risk or severity of adverse effects can be increased when Alosetron is combined with Paroxetine.
Tolcapone Tolcapone The metabolism of Alosetron can be decreased when combined with Tolcapone.
Citalopram Citalopram The risk or severity of adverse effects can be increased when Alosetron is combined with Citalopram.
Capecitabine Capecitabine The metabolism of Alosetron can be decreased when combined with Capecitabine.
Efavirenz Efavirenz The metabolism of Alosetron can be decreased when combined with Efavirenz.
Sildenafil Sildenafil The metabolism of Alosetron can be decreased when combined with Sildenafil.
Celecoxib Celecoxib The metabolism of Alosetron can be decreased when combined with Celecoxib.
Rosiglitazone Rosiglitazone The metabolism of Alosetron can be decreased when combined with Rosiglitazone.
Tolterodine Tolterodine Alosetron may increase the central nervous system depressant (CNS depressant) activities of Tolterodine.
Thalidomide Thalidomide Alosetron may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Nateglinide Nateglinide The metabolism of Alosetron can be decreased when combined with Nateglinide.
Levetiracetam Levetiracetam The risk or severity of adverse effects can be increased when Alosetron is combined with Levetiracetam.
Rabeprazole Rabeprazole The metabolism of Alosetron can be decreased when combined with Rabeprazole.
Terbinafine Terbinafine The metabolism of Terbinafine can be decreased when combined with Alosetron.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists